Suephy C Chen, MD, FAAD
SESSIONS
U064 Markers of Risk, Not Pre-Melanomas: Case-Based Management of Dysplastic Nevi
Mar 29, 2026
•
8:00 AM - 9:00 AM
•
Mile High 4A
DISCLOSURES
Sanofi Aventis – Other(Patent royalties or other compensation for Intellectual Property Rights); Syneos Health – Other(Patent royalties or other compensation for Intellectual Property Rights);